AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

$1.1M contract awarded to study counter-bioterrorism vaccine.

Vaccine Weekly

| February 04, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 FEB 4 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced that it has signed a new contract with DynPort Vaccine Company, LLC, (DVC) for a phase I study in the development of a recombinant vaccine designed to provide protection against botulinum neurotoxin.

The $1.1 million contract value of this award was included in Covalent's new business announcement dated December 15, 2003.

Botulinum neurotoxins, known primarily for causing cases of foodborne botulism, are produced by the bacterium Clostridium botulinum and the related species Clostridium baratii and Clostridium butyricum. These bacteria produce seven distinct types of botulinum neurotoxins. Most cases of botulism occur when a person swallows a substance that contains the neurotoxin. The neurotoxin then passes through the gastrointestinal tract and into the blood until it eventually reaches peripheral nerve endings where it has the capability to paralyze muscles, including those needed to breathe. The ultimate result can be death.

Kenneth M. Borow, MD, Covalent ...

Related articles from newspapers, magazines, journals, and more
Covalent Group, Inc. Announces Fourth Quarter and Full Year 2001 Conference...
Press release article from: PR Newswire March 12, 2002 700+ words
WAYNE, Pa. -- Covalent Group, Inc. will host a conference call to discuss Covalent Group's fourth quarter and full-year financial...call will be preceded by the release of Covalent Group's results. In addition to Covalent Group...
Covalent Group Announces $2 Million in Clinical Cardiovascular Study Contracts.
Press release article from: PR Newswire December 9, 2002 700+ words
Covalent Group, Inc. today announced new contracts...trials that has become the hallmark of Covalent Group. We look forward to the opportunity...additional new projects in the future." Covalent Group, Inc. is a comprehensive research...
Covalent Group, Inc. Announces Contracts for $4.8 Million to Provide NDA...
Press release article from: PR Newswire April 3, 2002 700+ words
WAYNE, Pa. -- Covalent Group, Inc. announced today the signing...Chief Executive Officer for Covalent Group, Inc. commented, "These contracts...value of new contracts signed by Covalent Group, Inc. year-to-date to...
Covalent Group, Inc. Announces $2.7 Million Contract To Conduct Clinical Trial...
Press release article from: PR Newswire March 6, 2002 700+ words
WAYNE, Pa. -- Covalent Group, Inc. announced today the signing...Chief Executive Officer at Covalent Group, Inc., commented: "We are...represents the first time that Covalent Group, Inc. has had the opportunity...
Covalent Group, Inc. Awarded Consulting Contracts With Three Biopharmaceutical...
Press release article from: PR Newswire September 28, 2004 700+ words
Covalent Group, Inc. , a leader in the design, development, and management...operations contracts with each of the sponsoring companies." About Covalent Group Covalent Group is a clinical research organization that is a leader in the design...
Covalent Group, Inc. Announces $2.6 Million of New Business Awards.
Press release article from: PR Newswire November 9, 2004 700+ words
Covalent Group, Inc. , a leader in the design, development, and management...This approximates our 2003 total of $21.7 million." About Covalent Group Covalent Group is a clinical research organization that is a leader in the design...
Covalent Group, Inc. to Report Third Quarter 2004 Results on November 15, 2004.
Press release article from: PR Newswire November 11, 2004 700+ words
Covalent Group, Inc. , a leader in the design, development, and management...international callers, and entering confirmation code 5384377. About Covalent Group Covalent Group is a clinical research organization that is a leader in the design...
Covalent Group, Inc. Appoints Christopher F. Meshginpoosh to Its Board of...
Press release article from: PR Newswire May 2, 2005 700+ words
...Pa., May 2 /PRNewswire-FirstCall/ -- Covalent Group, Inc. today announced the appointment of Christopher...direction and operational improvement." About Covalent Group Covalent Group is a clinical research organization that is...
Covalent Group Appoints Vice President of Global Regulatory Affairs.
Press release article from: PR Newswire February 3, 2003 700+ words
Covalent Group, Inc. announced today the appointment...the company. Dr. Cleveland joins Covalent Group from Celltech R&D PA, LLC...addition to our Covalent team." Covalent Group, Inc. is a comprehensive research...
Covalent Group, Inc. Announces The Appointment Of New Member To Its Board Of...
Press release article from: PR Newswire March 5, 2002 700+ words
WAYNE, Pa. -- Covalent Group, Inc. is pleased to announce...Chief Executive Officer at Covalent Group, Inc., commented: "I am truly...future growth strategies." The Covalent Group is a comprehensive research management...
For more facts and information, see all results

Source: HighBeam Research, $1.1M contract awarded to study counter-bioterrorism vaccine.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA